Renue Blue Skincare
Sister brand to Renue by Science — nanoliposome delivery technology applied to topical skin longevity.
Renue by Science's sister brand — same nanoliposome delivery science the parent company applies to internal NMN, now applied to topical skin longevity.
Renue Blue launched in 2024 as the skincare-vertical extension of Renue by Science's nanoliposome platform. The thesis: if encapsulation technology meaningfully improves bioavailability for oral and transdermal NMN, the same delivery science should improve absorption of topical actives — peptides, growth factors, antioxidants — into the dermal layer where they need to act.
The brand sits in the "skincare-as-longevity" segment alongside AV Laboratories (luxury longevity skincare), Aramore Skincare, and TIMEBEAM. The differentiator is the cross-pollination from the parent company — Renue Blue formulations explicitly leverage the nanoliposome IP that powers Renue by Science's liposomal NMN line, giving it a more rigorous biotech provenance than most "clean beauty" longevity-positioned brands.
For longevity buyers, Renue Blue fits when the goal is topical skin science as part of a broader longevity stack — paired with foundational supplements (Thorne, Momentous), an NMN/NAD bet (Wonderfeel or Renue by Science's internal line), and a structured topical routine. It's not the brand for buyers who want a 12-step Korean skincare regimen or who default to dermatologist-prescribed actives like tretinoin.
Longevity-stack buyers who want a topical skincare layer with biotech delivery-science provenance, particularly those already running Renue by Science internal NMN.
You want dermatologist-grade actives (tretinoin, hydroquinone) — those require prescription channels. Or you're cost-anchored to drugstore skincare ($15-30) and don't value the nanoliposome delivery angle.